Digital Health Global

JANUARY 10, 2024

LAUSANNE, Switzerland & SAN DIEGO–(BUSINESS WIRE)–Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in USA, are pleased to announce a collaborative partnership aimed at advancing the development of a cutting-edge cancer drug.

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

Healthcare IT Today

JANUARY 8, 2024

As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards.

Health IT 87

Health IT Drug Development Pharmaceuticals BioTech 87

Digital Health Global

APRIL 5, 2024

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Drug Discovery and Early Development Outsourcing Services” report has been added to ResearchAndMarkets.com’s offering. hike over 2022, with more than 6,100 molecules in active development. growth between 2023 to 2024.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

Digital Health Global

JANUARY 8, 2024

Top-10 global pharmaceutical companies are already benefiting from Medable’s novel technology, shaving weeks off build times. In 2024, expect to see more innovative technologies and new ways of delivering streamlined, patient-centric trials from Medable.” Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Lloyd Price

FEBRUARY 18, 2024

Drug development: Pharmaceutical companies like Novo Nordisk, Eli Lilly, and AstraZeneca led the development and commercialization of GLP-1 RAs. How will GLP-1s potentially affect HealthTech share prices in 2024? This sentiment might persist in 2024, further impacting share prices.

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Healthcare IT Today

JANUARY 23, 2024

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

Drug Development 97

Drug Development Pharmaceuticals Life Science BioTech 97